Innate immune receptor signaling induces transient melanoma dedifferentiation while preserving immunogenicity
Main Authors: | Dirk Schadendorf, Antje Sucker, Johannes Koch, Fang Zhao, Susanne Horn, Beatrice Thier, Simone Stupia, Alicia Brüggemann, Nina Schulze, Christoph Coch, Gunther Hartmann, Annette Paschen |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2022-06-01
|
Series: | Journal for ImmunoTherapy of Cancer |
Online Access: | https://jitc.bmj.com/content/10/6/e003863.full |
Similar Items
-
Innate RIG-I signaling restores antigen presentation in tumors and overcomes T cell resistance
by: Beatrice Thier, et al.
Published: (2021-01-01) -
Circulating cell‐free messenger RNA enables non‐invasive pan‐tumour monitoring of melanoma therapy independent of the mutational genotype
by: Lea Jessica Albrecht, et al.
Published: (2022-11-01) -
Orthanq: transparent and uncertainty-aware haplotype quantification with application in HLA-typing
by: Hamdiye Uzuner, et al.
Published: (2024-07-01) -
Clinical and genetic characteristics of BAP1-mutated non-uveal and uveal melanoma
by: Johanna Matull, et al.
Published: (2024-06-01) -
The Role of Inflammation in β-cell Dedifferentiation
by: Thierry M. Nordmann, et al.
Published: (2017-07-01)